NeuroPace Inc.
Company Snapshot
Founded: 1997
Entity Type: Public
Employees: 184
Region: U.S.
Revenue: $79.9 Millions
Revenue Year: 2024
Headquarter: California, U.S.
Key Geographics: North America
Corporate Address: 455 N. Bernardo Avenue Mountain View California 94043 U.S. Tel. +1-(650)-237-2700 www.neuropace.com
Company Overview
NeuroPace Inc., the U.S.-based medical device company, aims to enhance epilepsy quality of life by utilizing innovative brain-responsive neuromodulation technology, providing individualized, real-time treatment at the seizure source. The company is wholly engaged in offering its novel RNS system, considered the first and only brain-responsive neuromodulation system commercially available. Over 5,000 patients receive this system as of December 31, 2023. It will have 184 employees by the end of 2024.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
NeuroPace Inc. In News
Company's Business Segments
- Implantable Devices : The company provides RNS systems, a brain-responsive neuromodulation system designed for the treatment of medically refractory focal epilepsy by offering personalized and real-time treatment to eliminate the occurrence of debilitating seizures.
Applications/End User Industries
- Healthcare
BCC Research Beacon 